Complaint upheld against advertising of NeuroAD as Alzheimer’s disease treatment
The Advertising Standards Agency (ASA) have upheld a complaint made against Neuronix for their advertising of a medical device in relation to Alzheimer's disease. A complaint made against Neuronix for their advertising of NeuronAD as a medical device for the treatment of Alzheimer’s disease has today (21 March 2018) been upheld by the Advertising Standards…
